Seeking Alpha

catbird

catbird
Send Message
View as an RSS Feed
View catbird's Comments BY TICKER:
Latest  |  Highest rated
  • Wells Fargo Could Reach $60 - But It Won't Be Due To Interest Rate Rises [View article]
    Management leading strategy skills and performance deserve a price premium. Sticking with and adding to WFC. Loved the article.
    Jun 7, 2015. 08:28 AM | 4 Likes Like |Link to Comment
  • Wells Fargo Could Reach $60 - But It Won't Be Due To Interest Rate Rises [View article]
    WFC's premium based on superior management strategy skills and performance is deserved. Sticking with and adding to WFC. Loved the article.
    Jun 7, 2015. 08:24 AM | 13 Likes Like |Link to Comment
  • Financials on the move as rate hike draws nearer [View news story]
    Looks, sounds, and smells like a short, so it must be a short. As WFC and financials climb, time to cover and cut losses. Don't get squeezed.
    Jun 6, 2015. 02:06 PM | Likes Like |Link to Comment
  • Expanding Further On Gilead Sciences [View article]
    Terrible casting. The greedy lifeguard should be the PBMs who arbitrarily deny approvals for cure treatments, while they pocket insurance premiums so their execs pull down excessive salaries, bonuses, golden parachutes and other perks.
    Jun 6, 2015. 12:58 PM | 3 Likes Like |Link to Comment
  • Apple: May Has Come And Gone And No $140; Where We Stand [View article]
    P.T. Barnum said "There's a sucker born every minute." He comes in looking for the EGRESS and when he finds it he can EXIT. :-)
    Jun 3, 2015. 04:39 PM | Likes Like |Link to Comment
  • Apple: May Has Come And Gone And No $140; Where We Stand [View article]
    Everyone snickered when Carl Icahn called attention to how cheap Apple's stock was and how value could be enhanced by much larger buybacks possible by issuing debt, etc. Tim Cook didn't ignore his suggestions. He found a way to accomplish what has been a joyride for long term holders.

    A 7 for 1 stock split made APPL affordable to round lot investors. Huge buybacks, successful launch of the I-Watch, sustained results of IPhone 6 & Plus and more have driven the stock price to new highs.

    So Richard, much like CI, you've been pounding the table that APPL still is very cheap by many yardsticks. Is it too early to predict that by early next year when 2014 results are in, we'll have seen that the stock had risen high enough that TC had split it 2 for 1 and attracted new stockholders who had been so happy with Apple's products that they could purchase more affordable round lots as Xmas gifts.

    That's my prediction. I could be more outrageous than you because I don't have any followers:))
    Jun 3, 2015. 10:25 AM | Likes Like |Link to Comment
  • Apple: May Has Come And Gone And No $140; Where We Stand [View article]
    Richard, like your style, and responses to derisive comments are on target!

    As an APPLer, who came into Apple late after listening to the wife gloating after all the splits, etc., because she bought APPL at the original IPO.

    I became an Apple believer despite all the skeptic "one trick pony" proved wrong.

    I'm a patient octogenarian. Still, hanging out on blogs with all you young pups keeps me young. Keep smiling.
    Jun 1, 2015. 06:27 PM | 4 Likes Like |Link to Comment
  • Merger Activity Is A Bullish Indicator - Cramer's Mad Money (5/28/15) [View article]
    Have to love Cramer's program starting with an explanation of stock market action that day, and his astute analysis of probable causes (world events, what Janet Yellen, or Carl Icahn, Elon Musk, et alia said), or interest rates here or in Europe, Japan...

    Then soft lobs to CEOs being interviewed with no journalistic followup to the responses of his guests. He's the perfect host, praising the CEO and the company afterwards and in following days.

    For all his faults, he's the one who brought Gilead, Celgene, Regeneron, and the IBB ETF to my attention, so I thank him for convincing me to invest in them. Hope you're reading this, Jim, because we really do LUV you!!!
    May 30, 2015. 08:09 PM | 3 Likes Like |Link to Comment
  • Gilead Sciences Is Still Undervalued [View article]
    We've seen Gilead's TV commercial with the theme "now I'm going to do something about my HCV". Waiting for a new testimonial TV ad showing someone cured by S or H with prominent graphics NOT AN ACTOR, ONE OF MORE THAN (insert #) CURED BY H...Shouldn't you see.....
    May 29, 2015. 09:54 AM | Likes Like |Link to Comment
  • Why Can't Gilead Run? [View article]
    Closing at 111, it's nice to look back through the rear window at 90ish-110 pricing. Onward & Upward Momentum.
    May 18, 2015. 05:56 PM | Likes Like |Link to Comment
  • Why Can't Gilead Run? [View article]
    Should be a class action, bringing in many other HCV victims being warehoused by insurance companies until they get near death, or die, denied treatment by a proven cure. It's all about the $$$$$.
    May 18, 2015. 05:47 PM | 5 Likes Like |Link to Comment
  • Senator's HCV Rant Won't Slow Gilead [View article]
    Cooperman's hedge fund announced holdings,new,adds,cuts... Guess what. Apple and Gilead were liquidated. And he's supposed to be so smart. Even the great ones make mistakes.
    May 16, 2015. 11:26 AM | 3 Likes Like |Link to Comment
  • Senator's HCV Rant Won't Slow Gilead [View article]
    Let's give some comfort to all those GILD shorts who may be getting margin calls as Gilead keeps rising and gets more recognition and accumulation. Then they have to buy in to cover. How about a hug and a squeeeeeze!
    May 16, 2015. 10:57 AM | 2 Likes Like |Link to Comment
  • Senator's HCV Rant Won't Slow Gilead [View article]
    Gross Exaggeration belittling Gilead in its R&D perfecting the cure pill, conducting the necessary phases I,II,III and proving the benefits and advantages over existing treatments for approvals.
    Then it came up with the STR (single tablet regimen) combinations with other new drugs that work together for greater impact and efficacy, without serious side effects as in other competing products.
    R&D continues testing more drug combinations, seeking shortening the treatment period to attain full cure, thus lessening the overall cost.
    Negotiations with payers give greater rebates with higher volume, enabling more of the patient population to be treated and cured, a Win,Win,Win for Gilead, the PBM, and the patient.
    May 15, 2015. 03:47 PM | 5 Likes Like |Link to Comment
  • Senator's HCV Rant Won't Slow Gilead [View article]
    VA gets huge discounts for Harvoni, so Gilead shouldn't be a scapegoat. Washington pols should not be withholding funding for new cures just introduced like H & S, so that new cures can be found in oncology and cardio, etc.

    When are they going to stop impeding success by the private sector, and do their duty to support cures for the patient population.
    May 15, 2015. 11:15 AM | 4 Likes Like |Link to Comment
COMMENTS STATS
109 Comments
205 Likes